课题基金 / 基金详情

SIMS-ID: Smart Indoor Monitoring System-Integration and Deployment

SIMS-ID: Smart Indoor Monitoring System-Integration and Deployment
SIMS-ID:智能室内监控系统-集成与部署
批准号:
10019268
负责人:
金额:
$2.66万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2022
资助国家:
英国
项目状态:
已结题
起止时间:
2022 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Offices in the next decade will evolve into smart, flexible, sustainable and on-demand spaces. They will be designed to promote building operation automation and more flexibility of space usage. Also, the built environment accounts for more than 30% of the UK and US total carbon emissions. Determining occupants' density, movement, and proximity within buildings is a starting point for efficient utilisation of the indoor spaces.DIREK has recently developed the Smart Indoor Management System: SIMS (Patent Pending GB2111528.2), innovative technology for real-time, accurate and privacy-aware occupancy and activity monitoring. The technology enables buildings to move towards on-demand energy consumption and reduces the energy usage of buildings up to 30%.SIMS has successfully deployed in three different buildings across the UK and potential customers and collaborators have been identified.The Occupancy Sensor market registered a CAGR of 13.3% over the forecast period (2020-2025) to reach USD 3.6Billion with the market for residential buildings expected to grow at the highest. The US is the largest Occupancy Sensor market and accessing this huge market would enable Direk's covered area to grow at a rapid pace.The aim of this feasibility study is to target and establish a relationship with BMS providers and building owners in the United States and investigate the possibility of integrating our system with their platform. SIMS is a natural extension to their current product lines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
ID2驱动的生物钟紊乱通过PI3K-AKT信号轴调控前列腺癌细胞异质性和可塑性的研究
  • 批准号:
    JCZRLH202600193
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
Id2在胶质母细胞瘤中的作用及Id2/Oligo2促进胶质母细胞瘤EMT的分子机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    彭灿
  • 依托单位:
清肺合剂上调丁酸调控 HDACs/ID2/IL-12R 通 路增强 PD-1 抑制剂抗肺癌作用的机制研究
  • 批准号:
    Q24H290030
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    陈卓
  • 依托单位:
DRAL-Id3 轴在造血应激状态下调控 HSCs 自 我更新的分子机制研究
  • 批准号:
    Y24H080015
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    陈一瑞
  • 依托单位: